Literature DB >> 11465657

Bone mineral density in women with essential hypertension.

K Tsuda1, I Nishio, Y Masuyama.   

Abstract

Recent studies have reported the abnormalities in calcium metabolism at the systemic level in human hypertension as well as in experimental hypertension. Because bone is the largest store of calcium in the body, the bone calcium content and mineralization may represent the entire calcium balance. The present study was undertaken to investigate the bone mineral density (BMD) in women with essential hypertension by means of the dual-energy X-ray absorptiometric (DXA) method. The DXA analysis showed a significant decrease in BMD in female hypertensive subjects compared with normotensive subjects. In addition, the BMD was inversely correlated with systolic blood pressure in women. The 24-h urinary calcium excretion was significantly greater in female hypertensive subjects than in female normotensive subjects. Furthermore, the greater the urinary calcium excretion, the lower the BMD in women. The values of serum total calcium, total magnesium, ionized calcium, and 1, 25(OH)2 vitamin D were not different between hypertensive and normotensive subjects. The results of the present study demonstrated that DXA provided an index of whole calcium balance, and suggest that high blood pressure might be associated with reduced BMD in female hypertension.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465657     DOI: 10.1016/s0895-7061(01)01303-6

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  27 in total

Review 1.  The Key Role of the Blood Supply to Bone.

Authors:  Massimo Marenzana; Timothy R Arnett
Journal:  Bone Res       Date:  2013-09-25       Impact factor: 13.567

2.  Long-term use of angiotensin-converting enzyme inhibitors protects against bone loss in African-American elderly men.

Authors:  Nahid Rianon; Catherine G Ambrose; Hannah Pervin; Melissa Garcia; Scherezade K Mama; Ann V Schwartz; Brendan Lee; Tamara Harris
Journal:  Arch Osteoporos       Date:  2017-10-28       Impact factor: 2.617

3.  Bone mineral density in residents of care facilities for the aged and effect of pharmacotherapy.

Authors:  Takahiro Tokuda; Junichi Hasegawa; Akiko Matsuda; Hiroshi Hagino
Journal:  Yonago Acta Med       Date:  2014-04-28       Impact factor: 1.641

4.  Meta-analysis of hypertension and osteoporotic fracture risk in women and men.

Authors:  C Li; Y Zeng; L Tao; S Liu; Z Ni; Q Huang; Q Wang
Journal:  Osteoporos Int       Date:  2017-04-26       Impact factor: 4.507

Review 5.  Impact of the Autonomic Nervous System on the Skeleton.

Authors:  Florent Elefteriou
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

6.  Effect of Primary Hypertension on Treatment Outcomes of Patients with Postmenopausal Osteoporosis: A 5 Year Follow Up Retrospective Study.

Authors:  Volkan Yilmaz; Ebru Umay; Ibrahim Gundogdu; Fatma Aytul Cakcı
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-11-22

7.  Association between metabolic syndrome and bone mineral density in Korea: the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV), 2008.

Authors:  Taehun Kim; Sangshin Park; Yun-Suk Pak; Sangyoon Lee; Eun-Hee Lee
Journal:  J Bone Miner Metab       Date:  2013-04-01       Impact factor: 2.626

8.  A susceptibility haplotype within the endothelial nitric oxide synthase gene influences bone mineral density in hypertensive women.

Authors:  Monica Singh; Puneetpal Singh; Surinder Singh; Pawan Kumar Juneja; Taranpal Kaur
Journal:  J Bone Miner Metab       Date:  2013-11-10       Impact factor: 2.626

9.  Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study.

Authors:  D von Muhlen; S Safii; S K Jassal; J Svartberg; E Barrett-Connor
Journal:  Osteoporos Int       Date:  2007-05-11       Impact factor: 4.507

10.  Association between hypertension and fragility fracture: a longitudinal study.

Authors:  S Yang; N D Nguyen; J R Center; J A Eisman; T V Nguyen
Journal:  Osteoporos Int       Date:  2013-07-27       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.